Align Technology, Inc. (ALGN) vs ImmunityBio, Inc. (IBRX)
A side-by-side comparison of Align Technology, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALGN
Align Technology, Inc.
$141.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IBRX
ImmunityBio, Inc.
$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALGN vs IBRX
growth of $100 · dividends reinvested · last 10yALGN +52.2% (+4.3%/yr)IBRX +41.8% (+3.6%/yr)ALGN compounded faster over this window
ALGN IBRX
ALGN vs IBRX: by the numbers
- •IBRX is the larger company ($10.15B vs $10.13B market cap).
- •ALGN is profitable (9.99% net margin) while IBRX runs a net loss (-598.56%).
- •IBRX grew revenue faster over the past five years (202.97% vs 3.57% CAGR).
Metrics side by side
Valuation
| Metric | ALGN | IBRX |
|---|---|---|
| P/E ratio | 24.56 | N/A |
| Forward P/E | 12.55 | N/A |
| P/S ratio | 2.45 | 61.21 |
| P/B ratio | 2.39 | N/A |
| EV / EBITDA | 11.35 | N/A |
Profitability
| Metric | ALGN | IBRX |
|---|---|---|
| Gross margin | 66.48% | 94.63% |
| Operating margin | 13.33% | -226.00% |
| Net margin | 9.99% | -598.56% |
| ROE | 9.77% | N/A |
| ROIC | 8.90% | -45.63% |
Growth (annualized)
| Metric | ALGN | IBRX |
|---|---|---|
| Revenue CAGR (5Y) | 3.57% | 202.97% |
| EPS CAGR (5Y) | -24.16% | N/A |
| Total return CAGR (5Y) | -26.34% | 0.39% |
Some values include inputs from SEC filing.
Frequently asked
- Which has grown faster, ALGN or IBRX?
- Over the past five years, IBRX grew revenue faster — ALGN at a 3.57% CAGR versus IBRX at 202.97%.
- Is ALGN or IBRX more profitable?
- ALGN runs the higher net margin — ALGN at 9.99% versus IBRX at -598.56%.
- How have ALGN and IBRX total returns compared?
- Over the past 10 years, ALGN delivered 4.63% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Align Technology P/E ratioAlign Technology ROEImmunityBio ROEAlign Technology operating marginImmunityBio operating marginAlign Technology revenue growthImmunityBio revenue growthAlign Technology free cash flowImmunityBio free cash flow
Align Technology & ImmunityBio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.